相关实验视频
Updated: Jun 7, 2025

10:41
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
13.9K
介绍BPaL:来自LIFT-TB项目支持的国家的经验
D F Wares1, M Mbenga1, V Mirtskhulava1
1KNCV Tuberculosis Foundation, The Hague, The Netherlands.
PloS one
|November 19, 2024
概括
针对耐药结核病 (DR-TB) 的新的6个月BPaL疗法显示出高的成功率,并且在不同的国家都是可行的. 这种全口服治疗对DR-TB患者是安全有效的.
科学领域:
- 全球健康 全球健康
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐药结核病 (DR-TB) 治疗历史上涉及长期,有毒和效率较低的疗法.
- 最近的进展包括世界卫生组织的2020年指导方针,建议在经营研究 (OR) 中为选择的DR-TB患者提供6个月的全口服BPaL (bedaquiline, pretomanid, linezolid) 治疗方案.
研究的目的:
- 评估在操作研究 (OR) 条件下为DR-TB患者引入BPaL治疗方案的可行性,有效性和安全性.
- 通过LIFT-TB项目评估7个国家的实施过程和挑战.
主要方法:
- 在2020年11月至2023年3月期间,LIFT-TB项目在7个国家招募了574名DR-TB患者.
- 运营研究的目标集中在探索BPaL疗法引入的可行性,并估计其有效性和安全性.
主要成果:
- 在被录取的患者中,临时治疗成功率达到90.9% (280/308).
- 特别感兴趣的不良事件 (AESI) 是常见的,但可以管理的,只有一个患者停止治疗.
- 在研究期间没有观察到意外不良事件 (AE).
结论:
- 通过强有力的宣传和合作伙伴沟通,BPaL OR 方案在不同的国家环境中被证明是可行的.
- 临时结果显示患者反应很好,与临床试验结果相比.
- 可管理的不良事件和没有意想不到的AEs支持BPaL治疗方案在现实环境中的安全概况.
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis IV
133
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
133
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Pulmonary Tuberculosis III
305
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
305

